The development of gene transfer vectors from lentiviruses, such as the human immunodeficiency virus 1 (HIV-1), has opened exciting perspectives for the genetic treatment of a wide array of inherited and acquired diseases, because of their ability to achieve the efficient delivery, integration, and long-term expression of transgenes into dividing and nondividing cells both in vitro and in vivo.
No takes yet. Share an insight, caveat, or question.
Follenzi et al. (2003) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: